trending Market Intelligence /marketintelligence/en/news-insights/trending/_ng5ddniai17r8l30kfc_q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Phoenix Group to acquire Deutsche Bank's Abbey Life biz

Medical IoT Technology in US Hospitals Helps to Reduce Costs and Improve Care

Internet Traffic Spikes By One Third In March

How 37 Years of Default Data Can Prepare Us for the COVID-19 Fallout

US Pushes Pedal To The Metal On Broadband Speeds Ahead Of COVID-19 Outbreak

Phoenix Group to acquire Deutsche Bank's Abbey Life biz

Deutsche BankAG agreed to sell its U.K.-based Abbey Life business to  unitPhoenix Life HoldingsLtd. for £935 million in cash.

The business, which is held within Deutsche AssetManagement, comprises Abbey LifeAssurance Co. Ltd., Abbey Life Trustee Services Ltd. and Abbey LifeTrust Securities Ltd.

In a Sept. 28 statement, Deutsche Bank said the sale willhave a net positive capital impact upon closing and, on a pro-forma basis,would help boost its common equity Tier 1 capital ratio as of June 30 byapproximately 10 basis points.

The transaction, however, will result in an expected pretaxloss of approximately €800 million, primarily resulting from impairment ofgoodwill and intangible assets.

Phoenix Group said the same day that it will raise a totalof £735 million via a fully underwritten rights issue and £250 millionfrom a new bank facility to finance the acquisition. The rights issue will bemade on the basis of 7 rights issue shares issued at 508 pence apiece for every12 existing Phoenix Group shares.

The entire amount of the rights issue has been fullyunderwritten by HSBC Bank Plc; Morgan Stanley & Co. International plc; J.P.Morgan Securities Plc, which conducts its U.K. investment banking activities asJ.P. Morgan Cazenove; Commerzbank Aktiengesellschaft, London branch;and Natixis.

The group expects the acquisition to add £10 billion of AUMand approximately 735,000 policyholders, and to generate approximately £500million of aggregate cashflows between 2016 and 2020 and approximately £1.1billion in aggregate from 2021 onwards.

Phoenix Group said the deal will also support a proposeddividend increase in respect of 2017 to £197 million, representing a further 5%increase in dividend per share in addition to the 5% increase in dividend pershare as a result of its recent AXA deal, and equivalent to a total increase in the dividendper share of 10% from the 2015 level.

The transaction is subject to regulatory approvals,including that of the U.K. Prudential Regulation Authority. Theacquisition is expected to complete by the end of 2016.